Sofosbuvir may be a potential option in the treatment of COVID-19 based on the similarity
between the replication mechanisms of the HCV and the coronavirus. According the limited …

Zika virus (ZIKV) outbreak has emerged as a global health threat, particularly in tropical
areas, over the past few years. No antiviral therapy or vaccine is available at present. For …

A new Zika virus (ZIKV) outbreak started in 2015. According to the World Health
Organization, 84 countries confirmed ZIKV infection. RNA-dependent RNA polymerase …

With expanding recent outbreaks and a lack of treatment options, the Zika virus (ZIKV) poses
a severe health concern. The availability of ZIKV NS2B-NS3 co-crystallized structures paved …

Zika virus (ZIKV) is a global threat because it is spreading at an alarming rate because of its
wider range of transmission routes. The neuroteratogenic nature of ZIKV infection is posing …

Zika virus (ZIKV) has emerged as a global health threat due to its neuro-teratogenic effect
and wide range of transmission routes. Most recently, ZIKV infection has been linked with …

In December 2019, a new variant of SARS-CoV emerged, the so-called acute severe
respiratory syndrome coronavirus 2 (SARS-CoV-2). This virus causes the new coronavirus …

Mounting evidence indicates that Zika virus (ZIKV) is closely related to neurological
disorders such as microcephaly and Guillain-Barré syndrome. There are currently no …

Zika virus has spread rapidly in the Americas and has caused devastation of human
populations affected in these regions. The virus causes teratogenic effects involving the …

ABSTRACT In 2015–2016, in the Americas, and especially in northeast Brazil, a significant
number of cases of microcephaly and other congenital brain abnormalities were linked with …